These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19632622)

  • 1. The validity of the recommended criteria for termination of the ajmaline test in diagnosing Brugada syndrome.
    Meregalli PG; Veltmann C
    Heart Rhythm; 2009 Aug; 6(8):e1; author reply e1-2. PubMed ID: 19632622
    [No Abstract]   [Full Text] [Related]  

  • 2. Brugada-like changes in the peripheral leads during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):695-703. PubMed ID: 19545329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Intrahepatic cholestatic hepatitis following diagnostic ajmaline challenge'.
    Mellor G; Fellows I; Williams I
    Europace; 2013 Mar; 15(3):314. PubMed ID: 22804909
    [No Abstract]   [Full Text] [Related]  

  • 4. The ajmaline challenge and a strange ECG.
    Martini B
    Europace; 2009 Oct; 11(10):1406; author reply 1406-7. PubMed ID: 19797154
    [No Abstract]   [Full Text] [Related]  

  • 5. Ajmaline challenge in young individuals with suspected Brugada syndrome.
    Sorgente A; Sarkozy A; De Asmundis C; Chierchia GB; Capulzini L; Paparella G; Henkens S; Brugada P
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):736-41. PubMed ID: 21303388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ajmaline test].
    Said SM; Husser D; Bollmann A; Piorkowski C; Braun-Dullaeus RC
    Dtsch Med Wochenschr; 2010 Mar; 135(11):513-5. PubMed ID: 20221967
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholestatic hepatitis after diagnostic ajmaline challenge.
    Hamoir C; Dano H; Komuta M; Druez P; Negrin Dastis S
    Acta Gastroenterol Belg; 2017; 80(3):425-426. PubMed ID: 29560676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.
    Conte G; Dewals W; Sieira J; de Asmundis C; Ciconte G; Chierchia GB; Di Giovanni G; Baltogiannis G; Saitoh Y; Levinstein M; La Meir M; Wellens F; Pappaert G; Brugada P
    J Am Coll Cardiol; 2014 Jun; 63(21):2272-9. PubMed ID: 24681144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ajmaline challenge: to stop or not to stop..
    Probst V; Le Marec H
    Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing.
    Sacher F; Jesel L; Jais P; Haïssaguerre M
    Heart Rhythm; 2014 Apr; 11(4):732-4. PubMed ID: 23732228
    [No Abstract]   [Full Text] [Related]  

  • 17. Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms.
    Conte G; de Asmundis C; Ciconte G; Julià J; Sieira J; Chierchia GB; Brugada P
    JAMA; 2014 Nov; 312(19):2039-41. PubMed ID: 25399282
    [No Abstract]   [Full Text] [Related]  

  • 18. Ajmaline challenge in Brugada syndrome.
    Mandelburger D; Teubl A; Röggla G
    Resuscitation; 2007 Aug; 74(2):393-4. PubMed ID: 17521798
    [No Abstract]   [Full Text] [Related]  

  • 19. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome.
    Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER
    Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.